Search research articles
Contact Us
Filters
Showing results (371-380 of 551) with videos related to
Page
of 56
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation
Dieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
The Journal of Clinical Investigation
|
July 21, 2022
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia
Andres Chang, Anton M Sholukh, Andreas Wieland, et al.
The Lancet. Infectious Diseases
|
February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Glenda E Gray, Zoe Moodie, Barbara Metch, et al.
American Journal of Epidemiology
|
August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up
Ethan Ashby, Holly Janes, Dean Follmann, et al.
Open Forum Infectious Diseases
|
July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials
Valeria D Cantos, Moni Neradilek, Yunda Huang, et al.
Plos Computational Biology
|
February 22, 2020
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
Daniel B Reeves, Yunda Huang, Elizabeth R Duke, et al.
Ebiomedicine
|
November 9, 2020
The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies
Alyssa R Martin, Eshan U Patel, Charles Kirby, et al.
The New England Journal of Medicine
|
January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Lawrence Corey, Anna Wald, Raj Patel, et al.
Plos One
|
September 22, 2010
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
Jairam R Lingappa, James P Hughes, Richard S Wang, et al.
Journal of Virology
|
February 21, 2014
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection
Christine Johnston, Jia Zhu, Lichen Jing, et al.
Page
of 56
Search research articles
Search
Showing results (371-380 of 551) with videos related to
Sort By:
Page
of 56
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulation
Dieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
The Journal of Clinical Investigation
|
July 21, 2022
Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia
Andres Chang, Anton M Sholukh, Andreas Wieland, et al.
The Lancet. Infectious Diseases
|
February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Glenda E Gray, Zoe Moodie, Barbara Metch, et al.
American Journal of Epidemiology
|
August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up
Ethan Ashby, Holly Janes, Dean Follmann, et al.
Open Forum Infectious Diseases
|
July 22, 2024
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials
Valeria D Cantos, Moni Neradilek, Yunda Huang, et al.
Plos Computational Biology
|
February 22, 2020
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
Daniel B Reeves, Yunda Huang, Elizabeth R Duke, et al.
Ebiomedicine
|
November 9, 2020
The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies
Alyssa R Martin, Eshan U Patel, Charles Kirby, et al.
The New England Journal of Medicine
|
January 2, 2004
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Lawrence Corey, Anna Wald, Raj Patel, et al.
Plos One
|
September 22, 2010
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk
Jairam R Lingappa, James P Hughes, Richard S Wang, et al.
Journal of Virology
|
February 21, 2014
Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection
Christine Johnston, Jia Zhu, Lichen Jing, et al.
Page
of 56